Paragon Capital Management (Kansas)’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-58,191
Closed -$486K 56
2022
Q2
$486K Sell
58,191
-9,966
-15% -$139K 0.29% 34
2022
Q1
$1.56M Buy
68,157
+1,233
+2% +$30.1K 0.79% 25
2021
Q4
$1.85M Sell
66,924
-2,186
-3% -$58.5K 0.93% 24
2021
Q3
$1.93M Sell
69,110
-3,172
-4% -$90K 1.01% 25
2021
Q2
$2.12M Sell
72,282
-918
-1% -$27.8K 1.06% 25
2021
Q1
$2.17M Sell
73,200
-1,228
-2% -$36K 1.09% 25
2020
Q4
$1.55M Sell
74,428
-875
-1% -$16.3K 0.83% 24
2020
Q3
$1.17M Sell
75,303
-218
-0.3% -$3.75K 0.67% 23
2020
Q2
$1.38M Buy
+75,521
New +$1.33M 0.87% 23

Other funds holding BHC

Paragon Capital Management (Kansas)'s BHC Position: Q3 2022 in Review

Paragon Capital Management (Kansas) sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 58,191 shares — an estimated $486K sold.

Paragon Capital Management (Kansas) first reported a position in BHC in Q2 2020 and held it in 9 quarters. The position peaked at $2.17M in Q1 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Paragon Capital Management (Kansas) reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 58,191 Bausch Health shares in Q3 2022, an estimated $486K.
  • Paragon Capital Management (Kansas) first reported a position in Bausch Health in Q2 2020 and held it in 9 quarters.
  • Paragon Capital Management (Kansas)'s Bausch Health position peaked at $2.17M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q3 2022, filed 8 Nov 2022.